Background and purpose: The aim of the study was to evaluate the metabolic
correlates of Apolipoprotein E (APOE) genotype in amyotrophic lateral sclerosis
(ALS) and to investigate the role of e2 as a risk factor for cognitive impairment.
Methods: A total of 159 ALS cases underwent APOE and ALS-related genes
analysis, neuropsychological assessment and cerebral 18F-2-fluoro-2-deoxy-Dglucose
positron emission tomography. The APOE genotype was regressed
against whole brain metabolism as assessed by 18F-2-fluoro-2-deoxy-D-glucose
positron emission tomography, with age, sex, education, type of onset and
C9orf72 status as covariates.
Results: Brain metabolism was significantly positively correlated with APOE
genotype from e2/e2 to e3/e4 in the left prefrontal [Brodmann area (BA) 10],
orbitofrontal (BAs 11, 45, 47) and anterior cingulate (BA 32) cortices. There
was a tendency to a relative hypometabolism going towards the e2/e2 extreme.
Conclusions: We found a highly significant, relatively lower metabolism in
association with the e2 allele in extra-motor areas typically affected in frontotemporal
dementia (left prefrontal, orbitofrontal and anterior cingulate cortices),
strengthening the finding of a role of e2 as a risk factor for cognitive
impairment in ALS. Our data suggested a link between cholesterol homeostasis
and neurodegeneration.
